BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20081874)

  • 41. Dendritic cells and B cells cooperate in the generation of CD4(+)CD25(+)FOXP3(+) allogeneic T cells.
    Moore C; Sauma D; Reyes PA; Morales J; Rosemblatt M; Bono MR; Fierro JA
    Transplant Proc; 2010; 42(1):371-5. PubMed ID: 20172352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TGF-β1 maintains Foxp3 expression and inhibits glycolysis in natural regulatory T cells via PP2A-mediated suppression of mTOR signaling.
    Chen X; Feng L; Li S; Long D; Shan J; Li Y
    Immunol Lett; 2020 Oct; 226():31-37. PubMed ID: 32598969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune Tolerance of Human Dental Pulp-Derived Mesenchymal Stem Cells Mediated by CD4⁺CD25⁺FoxP3⁺ Regulatory T-Cells and Induced by TGF-β1 and IL-10.
    Hong JW; Lim JH; Chung CJ; Kang TJ; Kim TY; Kim YS; Roh TS; Lew DH
    Yonsei Med J; 2017 Sep; 58(5):1031-1039. PubMed ID: 28792150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dendritic cell SIRT1-HIF1α axis programs the differentiation of CD4+ T cells through IL-12 and TGF-β1.
    Liu G; Bi Y; Xue L; Zhang Y; Yang H; Chen X; Lu Y; Zhang Z; Liu H; Wang X; Wang R; Chu Y; Yang R
    Proc Natl Acad Sci U S A; 2015 Mar; 112(9):E957-65. PubMed ID: 25730867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of alanyl-aminopeptidase on CD4+CD25+ regulatory T-cells enhances expression of FoxP3 and TGF-beta1 and ameliorates acute colitis in mice.
    Bank U; Tadje J; Täger M; Wolke C; Bukowska A; Ittenson A; Reinhold D; Helmuth M; Ansorge S; Shakespeare A; Vieth M; Malfertheiner P; Naumann M; Lendeckel U
    Int J Mol Med; 2007 Oct; 20(4):483-92. PubMed ID: 17786278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells.
    Daniel C; Sartory N; Zahn N; Geisslinger G; Radeke HH; Stein JM
    J Immunol; 2007 Feb; 178(4):2458-68. PubMed ID: 17277153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody in DSS-induced mice colitis.
    Chen J; Xie L; Toyama S; Hünig T; Takahara S; Li XK; Zhong L
    Int Immunopharmacol; 2011 May; 11(5):610-7. PubMed ID: 21163250
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bacterial Immunogenicity Is Critical for the Induction of Regulatory B Cells in Suppressing Inflammatory Immune Responses.
    Maerz JK; Trostel C; Lange A; Parusel R; Michaelis L; Schäfer A; Yao H; Löw HC; Frick JS
    Front Immunol; 2019; 10():3093. PubMed ID: 32038631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suppression of allergic inflammation by allergen-DNA-modified dendritic cells depends on the induction of Foxp3+ Regulatory T cells.
    Wu K; Bi Y; Sun K; Xia J; Wang Y; Wang C
    Scand J Immunol; 2008 Feb; 67(2):140-51. PubMed ID: 18201369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DC expressing transgene Foxp3 are regulatory APC.
    Lipscomb MW; Taylor JL; Goldbach CJ; Watkins SC; Wesa AK; Storkus WJ
    Eur J Immunol; 2010 Feb; 40(2):480-93. PubMed ID: 19941313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulatory Dendritic Cells Induced by Mesenchymal Stem Cells Ameliorate Dextran Sodium Sulfate-Induced Chronic Colitis in Mice.
    Jo H; Eom YW; Kim HS; Park HJ; Kim HM; Cho MY
    Gut Liver; 2018 Nov; 12(6):664-673. PubMed ID: 29938461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transforming growth factor-β-Expressing Mesenchymal Stem Cells Induce Local Tolerance in a Rat Liver Transplantation Model of Acute Rejection.
    Tang J; Yang R; Lv L; Yao A; Pu L; Yin A; Li X; Yu Y; Nyberg SL; Wang X
    Stem Cells; 2016 Nov; 34(11):2681-2692. PubMed ID: 27333806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. iPSC-Derived Regulatory Dendritic Cells Inhibit Allograft Rejection by Generating Alloantigen-Specific Regulatory T Cells.
    Cai S; Hou J; Fujino M; Zhang Q; Ichimaru N; Takahara S; Araki R; Lu L; Chen JM; Zhuang J; Zhu P; Li XK
    Stem Cell Reports; 2017 May; 8(5):1174-1189. PubMed ID: 28434942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carbonic Anhydrate I Epitope Peptide Improves Inflammation in a Murine Model of Inflammatory Bowel Disease.
    Yagi S; Abe M; Yamashita M; Mori K; Yamanishi H; Arimitsu E; Yamamoto Y; Takeshita E; Ikeda Y; Hiasa Y
    Inflamm Bowel Dis; 2016 Aug; 22(8):1835-46. PubMed ID: 27104825
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The similarities between smDCs and regDCs in alleviating the immune injury caused by transplantation of hepatocytes differentiated from ESCs.
    Zhang C; Liao W; Cai B; Liu F; Ke Q; Zhu X; He X; Hu A
    Stem Cell Res Ther; 2017 Nov; 8(1):266. PubMed ID: 29157299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1.
    Gil-Guerrero L; Dotor J; Huibregtse IL; Casares N; López-Vázquez AB; Rudilla F; Riezu-Boj JI; López-Sagaseta J; Hermida J; Van Deventer S; Bezunartea J; Llopiz D; Sarobe P; Prieto J; Borrás-Cuesta F; Lasarte JJ
    J Immunol; 2008 Jul; 181(1):126-35. PubMed ID: 18566377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunomodulatory Effect of Urine-derived Stem Cells on Inflammatory Bowel Diseases via Downregulating Th1/Th17 Immune Responses in a PGE2-dependent Manner.
    Zhou C; Wu XR; Liu HS; Liu XH; Liu GH; Zheng XB; Hu T; Liang ZX; He XW; Wu XJ; Smith LC; Zhang Y; Lan P
    J Crohns Colitis; 2020 Jun; 14(5):654-668. PubMed ID: 31841595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo.
    Jaen O; Rullé S; Bessis N; Zago A; Boissier MC; Falgarone G
    Immunology; 2009 Jan; 126(1):35-44. PubMed ID: 18754812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells.
    Prochazkova J; Fric J; Pokorna K; Neuwirth A; Krulova M; Zajicova A; Holan V
    Immunology; 2009 Sep; 128(1 Suppl):e670-8. PubMed ID: 19740328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Garp as a therapeutic target for modulation of T regulatory cell function.
    Shevach EM
    Expert Opin Ther Targets; 2017 Feb; 21(2):191-200. PubMed ID: 28001437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.